LD-2 disclosure · 4th Quarter - Report
APOTEX CORPORATION
Client
- Description
- Generic pharmaceutical manufacturer
- Location
- Florida · United States of America
Registrant
- Description
- Government advisory firm
- Location
- Key Largo, Florida, United States of America
Lobbying activities
2 issuesManufacturing
Policies relating to strengthening domestic manufacturing of active pharmaceutical ingredients and finished dosages.
LobbyistsHENRY W MENN iii
Covered position (HENRY W MENN iii): Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner.
TargetedSENATE · HOUSE OF REPRESENTATIVES · Commerce, Dept of (DOC)
Health Issues
S.2910 - Expanding Access to Low-Cost Generics Act of 2021; S. 2740-Promoting Readiness and Ensuring Proper Active Pharmaceutical Ingredient Reserves of Essential Medicines (PREPARE) Act; H.R. 5376-Build Back Better Act.
LobbyistsHENRY W MENN iii
Covered position (HENRY W MENN iii): Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner.
TargetedSENATE · HOUSE OF REPRESENTATIVES · Commerce, Dept of (DOC)